Cite
HARVARD Citation
Thomas, M. et al. (n.d.). 1672PMaintenance treatment with the TLR9 agonist lefitolimod in extensive-stage small-cell lung cancer (ES-SCLC): Final results from the randomized phase II IMPULSE study. Annals of oncology. p. . [Online].